Randomized clinical trial comparing high versus standard dose of ribavirin plus peginterferon alfa-2a in hepatitis C genotype 3 and high viral load. Dargen-3 study. [electronic resource]
Producer: 20150402Description: 1-8 p. digitalISSN:- 0210-5705
- Adult
- Aged
- Aged, 80 and over
- Antiviral Agents -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Erythropoietin -- administration & dosage
- Female
- Genotype
- Hepacivirus -- classification
- Hepatitis C, Chronic -- blood
- Humans
- Interferon-alpha -- administration & dosage
- Male
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- Recombinant Proteins -- administration & dosage
- Ribavirin -- administration & dosage
- Treatment Outcome
- Viral Load
- Viremia -- blood
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.